Cannara Biotech Inc. (LOVE.V)
CAD 0.68
(0.0%)
CAD 0.68
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 39.73 Million CAD | -13.99% |
| 2022 | 46.2 Million CAD | 126.85% |
| 2021 | 20.36 Million CAD | 63.94% |
| 2020 | 12.42 Million CAD | -5.05% |
| 2019 | 13.08 Million CAD | 1.0% |
| 2018 | 12.95 Million CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 39.93 Million CAD | -0.58% |
| 2024 Q3 | 38.94 Million CAD | 659.37% |
| 2024 Q2 | 5.63 Million CAD | -86.99% |
| 2023 Q1 | 46.07 Million CAD | -0.28% |
| 2023 Q4 | 39.73 Million CAD | -3.1% |
| 2023 FY | 39.73 Million CAD | -13.99% |
| 2023 Q3 | 41.01 Million CAD | -0.63% |
| 2023 Q2 | 41.27 Million CAD | -10.43% |
| 2022 Q2 | 30.28 Million CAD | 2.01% |
| 2022 Q1 | 29.68 Million CAD | 45.77% |
| 2022 FY | 46.2 Million CAD | 126.85% |
| 2022 Q4 | 46.2 Million CAD | 52.22% |
| 2022 Q3 | 30.35 Million CAD | 0.21% |
| 2021 Q4 | 20.36 Million CAD | 27.14% |
| 2021 Q2 | 16.14 Million CAD | 21.68% |
| 2021 FY | 20.36 Million CAD | 63.94% |
| 2021 Q1 | 13.27 Million CAD | 6.81% |
| 2021 Q3 | 16.01 Million CAD | -0.79% |
| 2020 FY | 12.42 Million CAD | -5.05% |
| 2020 Q4 | 12.42 Million CAD | 106.4% |
| 2020 Q3 | 6.01 Million CAD | -14.72% |
| 2020 Q1 | 7.09 Million CAD | -45.81% |
| 2020 Q2 | 7.05 Million CAD | -0.45% |
| 2019 Q4 | 13.08 Million CAD | -0.29% |
| 2019 FY | 13.08 Million CAD | 1.0% |
| 2019 Q3 | 13.12 Million CAD | -0.26% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q2 | 13.15 Million CAD | 0.0% |
| 2018 FY | 12.95 Million CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 583.58 Thousand CAD | -6709.373% |
| CanadaBis Capital Inc. | 5.91 Million CAD | -571.673% |
| Decibel Cannabis Company Inc. | 32.34 Million CAD | -22.847% |
| Delivra Health Brands Inc. | 1.78 Million CAD | -2126.249% |
| Entourage Health Corp. | 5.79 Million CAD | -585.969% |
| Lifeist Wellness Inc. | 868.65 Thousand CAD | -4474.711% |
| Medicure Inc. | 229 Thousand CAD | -17253.079% |
| PharmaCielo Ltd. | 2.55 Million CAD | -1456.292% |
| Rubicon Organics Inc. | - CAD | -Infinity% |
| BioSyent Inc. | 1.03 Million CAD | -3729.369% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -99246.375% |